HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Campaign Prepares “Wish List” Of Chemicals For Walmart To Target

This article was originally published in The Rose Sheet

Executive Summary

Triclosan, phthalates, formaldehyde, hydroquinone and synthetic musks are among chemicals the Campaign for Safe Cosmetics hopes will be targeted for removal under Walmart’s recently announced sustainable chemistry program for cosmetic products in its stores. CSC will work with the mega-retailer, providing “technical expertise,” according to co-founder Janet Nudelman.

You may also be interested in...



Walmart Program Seeks Greener Beauty, Greater Supplier Transparency

Walmart aims to reduce or eliminate high-priority toxins from its beauty offering with a program announced Sept. 12. The Campaign for Safe Cosmetics celebrates the move and calls on Target to implement a similar safe-cosmetics policy in its stores.

IFRA Report To EC Addresses Trade Secrets, Dangers Of Full Disclosure

Safeguarding trade secrets “remains the most practical and efficient means of protecting the intangible assets” produced by innovation in the fragrance industry, IFRA asserts in a recently issued report. Threats to the industry’s intellectual property, including calls for full disclosure of formulas, put the market at risk, the group says.

China Regulatory Probe Slows Nu Skin Growth After Record Year

The firm’s recent explosive growth is expected to slow substantially in the first quarter – to between 20% and 24% – but Nu Skin is confident the steps it is taking in China “make our long-term success more likely.” Analysts have faith in the firm as it works with Chinese officials to resolve an investigation into its business practices.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018728

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel